We had earlier reported that aminoisoquinoline benzamides are dual FLT3-Src-family kinase inhibitors with potent activities against FLT3-ITD harboring AML cell lines MV4–11 and MOLM-14 [24]. Here, FLT3 is linked to acute myeloid leukemia.